HanyElmariahMD

Hematologic Oncology

Physician

Overview of Dr. Elmariah

Dr. Hany Elmariah is an oncologist in Tampa, FL and is affiliated with H. Lee Moffitt Cancer Center and Research Institute. He received his medical degree from University of Florida College of Medicine and has been in practice 7 years. He is one of 170 doctors at H. Lee Moffitt Cancer Center and Research Institute who specialize in Oncology. He has more than 40 publications and over 500 citings.

Office
12902 USF Magnolia Drive
Tampa, FL 33612
Book by Phone+1(253) 259-2815

Education & Training

Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2015 - 2018
Duke University HospitalResidency, Internal Medicine, 2011 - 2014
University of Florida College of MedicineClass of 2011

Certifications & Licensure

FL State Medical License 2014 - 2026
MD State Medical License 2015 - 2018
NC State Medical License 2011 - 2014
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies Start of enrollment: 2019 Dec 06
Active, not recruiting
Phase 2
CD8 Depleted, Non-engrafting, HLA Mismatched Unrelated Infusion With MDS and Secondary AML Start of enrollment: 2021 Jan 14
Active, not recruiting
Phase 1, Phase 2

Publications & Presentations

PubMed

101 citations
Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis.
Javier Bolaños-Meade, Mehdi Hamadani, Juan Wu, Monzr M Al Malki, Michael J Martens
The New England Journal of Medicine. 2023-06-22
26 citations
A phase 2 trial of GVHD prophylaxis with PTCy, sirolimus, and MMF after peripheral blood haploidentical transplantation
Nelli Bejanyan, Joseph Pidala, Xuefeng Wang, Ram Thapa, Taiga Nishihori
Blood Advances. 2021-03-09
9 citations
Cardiac events after standard of care idecabtagene vicleucel for relapsed and refractory multiple myeloma.
Dae Hyun Lee, Abhishek Kumar, Turab Mohammed, Lauren C Peres, Melissa Alsina
Blood Advances. 2023-08-22

Abstracts/Posters

Clearance of Somatic Gene Mutations in Patients with Acute Myeloid Leukemia Prior to Allogeneic Hematopoietic Cell Transplantation (HCT) Predicts Outcome
Hany Elmariah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Allogeneic Transplantation for Myelodysplastic Syndrome in Adults over 50 Years Old Using Reduced Intensity/Non-Myeloablative Conditioning: Haploidentical Relative Ver...
Hany Elmariah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Impact of TBI-Based Conditioning Regimen on Outcomes of Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplant: Systematic Revi...
Hany Elmariah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Impact of TP53 gene Mutation Clearance and Conditioning Intensity on Outcome in MDS or AML Patients Prior to Allogeneic Stem Cell Transplantation
Hany Elmariah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Join now to see all

Lectures

CD34+ Cell Dose Influences Survival after Allogeneic Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019